NutriStack
What is happening. Milk thistle (silymarin) has been reported to modulate CYP3A4 and CYP2C9 activity in some experimental settings, and these enzymes contribute to voriconazole metabolism. Although clinical pharmacokinetic effects are modest and inconsistent, patients sometimes take milk thistle for liver support precisely when voriconazole, a drug associated with hepatotoxicity, is in use. Combining a marginally active herbal CYP modulator with a narrow-therapeutic-window antifungal warrants attention, especially since voriconazole levels are highly variable and routinely monitored.
Mechanism. Silymarin constituents can weakly inhibit or modulate CYP3A4 and CYP2C9, the principal voriconazole-metabolizing enzymes, with the potential to alter antifungal exposure; the net clinical effect is small and variable.
Recommendation. Tell your prescriber if you take milk thistle while on voriconazole. It is not strictly prohibited, but voriconazole already requires therapeutic drug monitoring and liver function testing, so disclose the supplement so trough levels and LFTs can be interpreted correctly. Do not start or stop milk thistle abruptly during therapy without informing the team.